-transparent.png){kind=logo}
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines. 1988
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
Department of Medicinal Chemistry, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
A series of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines was prepared by standard methodology. These compounds were tested in vitro as antagonists of the binding of [125I]cholecystokinin (CCK) to rat pancreas and guinea pig brain receptors and of the binding of [125I]gastrin to guinea pig gastric glands. All compounds proved to have greater affinity for the peripheral CCK receptor with some analogues having IC50's in the subnanomolar range. In vivo activity of selected compounds in mice is presented and the structure/activity profile of this class of benzodiazepines as CCK antagonists is discussed.
Related Publications
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
August 1980,
Journal of medicinal chemistry,
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
June 1989,
Journal of medicinal chemistry,
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
March 2015,
Molecules (Basel, Switzerland),
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
August 2015,
Archiv der Pharmazie,
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
August 2005,
Biological & pharmaceutical bulletin,
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
June 1980,
Journal of medicinal chemistry,
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
August 2007,
Chemical biology & drug design,
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
April 2020,
Scientific reports,
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
March 2008,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M G Bock, and
R M DiPardo, and
B E Evans, and
K E Rittle, and
D F Veber, and
R M Freidinger, and
R S Chang, and
V J Lotti
September 2006,
The Journal of pharmacy and pharmacology,
